Hider, Robert C.

Chemistry and biology of siderophores

Hider, R. C., & Kong, X. (2010) · Natural Product Reports

Microbial Natural Products and BiosynthesisBacterial Genetics and Biotechnology

Cited by 1,722

Identification of an Intestinal Heme Transporter

Shayeghi, M., Latunde-Dada, G. O., Oakhill, J. S., Laftah, A. H., Takeuchi, K., Halliday, N., Khan, Y., Warley, A., McCann, F. E., Hider, R. C., et al. (2005) · Cell

Iron Metabolism and DisordersHemoglobin structure and function

Cited by 755

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy

Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology

Alzheimer's disease research and treatmentsHeavy Metal Exposure and Toxicity

Cited by 411

Feruloyl-CoA 6'-Hydroxylase1-Dependent Coumarins Mediate Iron Acquisition from Alkaline Substrates in Arabidopsis

Schmid, N. B., Giehl, R. F. H., Doll, S., Mock, H.-P., Strehmel, N., Scheel, D., Kong, X., Hider, R. C., & von Wiren, N. (2014) · PLANT PHYSIOLOGY

Plant Micronutrient Interactions and EffectsIron Metabolism and Disorders

Cited by 334

Design of iron chelators with therapeutic application

Liu, Z. D., & Hider, R. C. (2002) · Coordination Chemistry Reviews

Iron Metabolism and DisordersMetal complexes synthesis and properties

Cited by 287

Glutathione: a key component of the cytoplasmic labile iron pool

Hider, R. C., & Kong, X. L. (2011) · BioMetals

Iron Metabolism and DisordersMetalloenzymes and iron-sulfur proteins

Cited by 281

Design of clinically useful iron(III)‐selective chelators

Liu, Z. D., & Hider, R. C. (2002) · Medicinal Research Reviews

Iron Metabolism and DisordersMetal complexes synthesis and properties

Cited by 266

Siderophore mediated absorption of iron

Hider, R. C. (2007) · Structure and Bonding

Iron Metabolism and DisordersMicrobial Natural Products and Biosynthesis

Cited by 261

Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo

Rooyakkers, T. M., Stroes, E. S. G., Kooistra, M. P., Van Faassen, E. E., Hider, R. C., Rabelink, T. J., & Marx, J. J. M. (2002) · European Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsIron Metabolism and Disorders

Cited by 157

Design of iron chelators with therapeutic application

Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012) · Dalton Transactions

Iron Metabolism and DisordersHemoglobinopathies and Related Disorders

Cited by 136

Common Presence of Non–Transferrin-Bound Iron Among Patients With Type 2 Diabetes

Lee, D.-H., Liu, D. Y., Jacobs, D. R., Shin, H.-R., Song, K., Lee, I.-K., Kim, B., & Hider, R. C. (2006) · Diabetes Care

Iron Metabolism and DisordersTrace Elements in Health

Cited by 128

Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform

Jacobs, E. M. G., Hendriks, J. C. M., van Tits, B. L. J. H., Evans, P. J., Breuer, W., Liu, D. Y., Jansen, E. H. J. M., Jauhiainen, K., Sturm, B., Porter, J. B., et al. (2005) · Analytical Biochemistry

Iron Metabolism and DisordersClinical Laboratory Practices and Quality Control

Cited by 101

The Environment of the Lipoxygenase Iron Binding Site Explored with Novel Hydroxypyridinone Iron Chelators

Abeysinghe, R. D., Roberts, P. J., Cooper, C. E., MacLean, K. H., Hider, R. C., & Porter, J. B. (1996) · Journal of Biological Chemistry

Metal-Catalyzed Oxygenation MechanismsInflammatory mediators and NSAID effects

Cited by 70

The Design of Orally Active Iron Chelators

HIDER, R. C., & ZHOU, T. (2005) · Annals of the New York Academy of Sciences

Iron Metabolism and DisordersMetal complexes synthesis and properties

Cited by 64

Iron deficiency impairs Intra-hepatic lymphocyte mediated immune response

Bonaccorsi-Riani, E., Danger, R., Lozano, J. J., Martinez-Picola, M., Kodela, E., Mas-Malavila, R., Bruguera, M., Collins, H. L., Hider, R. C., Martinez-Llordella, M., et al. (2015) · PLOS ONE

Iron Metabolism and DisordersT-cell and B-cell Immunology

Cited by 57

The antimalarial effect of iron chelators: Studies in animal models and in humans with mild falciparum malaria

Hershko, C., Gordeuk, V. R., Brittenham, G. M., Thuma, P. E., Theanacho, E. N., Spira, D. T., Hider, R. C., & Peto, T. E. A. (1992) · Journal of Inorganic Biochemistry

Malaria Research and ControlIron Metabolism and Disorders

Cited by 57

Comparative Radical Scavenging Ability of Bidentate Iron(III) Chelators

Kayyali, R., Pannala, A. S., Khodr, H., & Hider, R. C. (1998) · Biochemical Pharmacology

Free Radicals and AntioxidantsAntioxidant Activity and Oxidative Stress

Cited by 46

Structural Analysis of Cytochrome P450 105N1 Involved in the Biosynthesis of the Zincophore, Coelibactin

Zhao, B., Moody, S. C., Hider, R. C., Lei, L., Kelly, S. L., Waterman, M. R., & Lamb, D. C. (2012) · International Journal of Molecular Sciences

Microbial Natural Products and BiosynthesisMetal-Catalyzed Oxygenation Mechanisms

Cited by 42

Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis

Georgiou, N. A., Van Der Bruggen, T., Oudshoorn, M., Hider, R. C., Marx, J. J. M., & Van Asbeck, B. S. (2002) · European Journal of Clinical Investigation

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 38

The Treatment of Malaria with Iron Chelators

Hider, R. C., & Liu, Z. (1997) · Journal of Pharmacy and Pharmacology

Malaria Research and ControlIron Metabolism and Disorders

Cited by 26